Bosnia and Herzegovina: Coronavirus

(asked on 26th February 2021) - View Source

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the accuracy of recent claims made by the COVAX facility in relation to Bosnia and Herzegovina's vaccine distribution capability; and what steps he is taking with international partners to support vaccine delivery in Bosnia and Herzegovina.


Answered by
Wendy Morton Portrait
Wendy Morton
This question was answered on 4th March 2021

COVAX is the key multilateral mechanism for delivering global equitable access to vaccines, and hopes to deliver two billion doses to 192 countries in less than a year. It has been working with its members - including Bosnia and Herzegovina - on distribution and roll-out plans, and has recently announced the first tranche of vaccine allocations, which will provide protection to the most vulnerable across the globe. We understand Bosnia and Herzegovina will receive both Pfizer-BioNTech and AstraZeneca-Oxford vaccines in the coming months as part of this first tranche. It is for members to work with COVAX directly, where appropriate involving relevant partners such as regional bodies, on procurement, delivery and distribution of doses. The UK will continue to put equitable global access to COVID-19 vaccines at the heart of our international approach. We remain a leading supporter of COVAX and, having already contributed £548 million, I am pleased to say we are one of the largest donors to its Advanced Market Commitment, which provides donor-funded vaccine doses to the 92 most vulnerable countries.

Reticulating Splines